The inclusion in the State Register of Medicinal Products of the Russian Federation of the pharmaceutical substance Temozolomide produced by the company Excella GmbH & Co. KG, Germany, has been successfully completed in Russia. This active pharmaceutical ingredient is intended for production of chemotherapy drugs used to treat a type of brain tumour in oncology. Temozolomide is available in oral nonsterile grade.
For more information about the product visit our sales portal imcobuy: www.imcobuy.com or contact us.
New oncological substance Temozolomide available in Russia
